13F-HR filed by Endurant Capital Management LP
Endurant Capital Management LP filed this 13F-HR for the quarter ended 2023-12-31, filed 2024-02-14, with 25 holding rows worth $17,441,623.
- Accession
- 0001633055-24-000002
- Filer
- CIK 1633055
- Filed
- 2024-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2023
A holdings report, 25 entries on the cover page, a total value of $17,441,623 stated on the cover page (in dollars after the unit check, H1), rows summing to $17,441,623 with VALUE read as dollars as filed, 13F file number 028-16634. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Boston Scientific Corporation | 101137107 | COM | 39,108 | $2,260,833 | dollars as filed | |
| Thermo Fisher Scientific Inc. | 883556102 | COM | 3,794 | $2,013,817 | dollars as filed | |
| AXONICS INC | 05465P101 | COM | 24,871 | $1,547,722 | dollars as filed | |
| Elevance Health, Inc. | 036752103 | COM | 2,627 | $1,238,788 | dollars as filed | |
| ICON PUB LTD CO SHS | G4705A100 | Stock | 3,659 | $1,035,753 | dollars as filed | |
| LABORATORY CORP OF AMERICA | 50540R409 | COM NEW | 3,984 | $905,523 | dollars as filed | |
| ENCOMPASS HEALTH CORP COM | 29261A100 | Stock | 12,870 | $858,686 | dollars as filed | |
| INSULET CORP COM | 45784P101 | Stock | 3,906 | $847,524 | dollars as filed | |
| HOLOGIC INC | 436440101 | COM | 11,631 | $831,035 | dollars as filed | |
| ZIMMER BIOMET HOLDINGS INC COM | 98956P102 | Stock | 5,646 | $687,118 | dollars as filed | |
| AVANTOR INC COM | 05352A100 | Stock | 24,598 | $561,572 | dollars as filed | |
| TENET HEALTHCARE CORP COM NEW | 88033G407 | Stock | 7,303 | $551,888 | dollars as filed | |
| Pfizer Inc. | 717081103 | COM | 15,790 | $454,594 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 4,650 | $448,353 | dollars as filed | |
| ORTHOPEDIATRICS CORP | 68752L100 | COMMON STOCK | 13,428 | $436,544 | dollars as filed | |
| Cigna Corporation | 125523100 | COM | 1,384 | $414,439 | dollars as filed | |
| QUIDELORTHO CORP COM | 219798105 | Stock | 5,147 | $379,334 | dollars as filed | |
| THE COOPER COMPANIES | 216648402 | COM NEW | 988 | $373,899 | dollars as filed | |
| SABRA HEALTH CARE REIT INC COM | 78573L106 | REIT | 20,017 | $285,643 | dollars as filed | |
| AGILENT TECHNOLOGIES INC COM | 00846U101 | Stock | 1,900 | $264,157 | dollars as filed | |
| FORTREA HLDGS INC COMMON STOCK | 34965K107 | Stock | 6,988 | $243,881 | dollars as filed | |
| QIAGEN NV | N72482123 | SHS NEW | 5,219 | $226,661 | dollars as filed | |
| HUMANA INC COM | 444859102 | Stock | 469 | $214,713 | dollars as filed | |
| CENCORA INC COM | 03073E105 | Stock | 990 | $203,326 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 148,400 | $155,820 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001633055-24-000002 | this filing | 2024-02-14 | acceptance time not in the bulk data set |